Departamento de Clínica of Academia Medico Homeopática de Barcelona (AMHB), Calle Corcega 370 2° 2ª, Barcelona, Spain.
Departamento de Clínica of Academia Medico Homeopática de Barcelona (AMHB), Plaça Mons, 1, Barcelona, Spain.
Homeopathy. 2021 Nov;110(4):236-243. doi: 10.1055/s-0041-1727204. Epub 2021 May 25.
Homeopathy has had documented success treating epidemics in the last two centuries. We aimed to obtain a clear homeopathic clinical picture of coronavirus disease 2019 (COVID-19) and postulate the genus epidemicus of the disease in order to inform and enhance future treatment and prophylaxis options.
We conducted a prospective case series study, collecting data from 19 homeopaths in Catalonia, Spain, from patients who presented with fever and/or cough and/or breathlessness and/or confirmed COVID-19 infection or close contact with a confirmed case. We included 107 patients, and data were recorded through a checklist questionnaire on the day of the case analysis and at day 10-15 after commencing treatment. Symptoms were collected and analyzed with the help of homeopathic repertories.
A total of 103 cases were mild or moderate; four were severe. The severe cases were excluded from the analysis and the 103 mild and moderate cases were analyzed and a clear overall clinical picture with mental, general, and particular symptoms was achieved. Eighty-eight cases had a complete recorded follow-up. The most prescribed medicines were , , and , whilst those with the best rates of good response were , and . Time to full recovery after homeopathic treatment ranged from 3.5 to 14.4 days, depending on the medicine used. The potency 200c was associated with faster rates of full recovery and a lesser need to change remedy.
We have defined the symptomatic homeopathic characteristics of mild and moderate COVID-19 in Spain and established a set of medicines that might be useful to consider as effective genus epidemicus.
顺势疗法在过去两个世纪中成功治疗了许多流行病。我们旨在获得 2019 年冠状病毒病（COVID-19）的清晰顺势疗法治愈临床特征，并推测该病的传染病，以提供信息并增强未来的治疗和预防选择。
我们进行了一项前瞻性病例系列研究，从西班牙加泰罗尼亚的 19 位顺势疗师处收集了有发热和/或咳嗽和/或呼吸困难和/或确诊 COVID-19 感染或与确诊病例密切接触的患者的数据。我们共纳入 107 例患者，并在病例分析当天和开始治疗后 10-15 天通过检查表问卷记录数据。通过使用顺势疗法药物索引收集和分析症状。
共有 103 例为轻症或中度；4 例为重症。重症病例被排除在分析之外，对 103 例轻症和中度病例进行了分析，得出了清晰的整体临床特征，包括精神、全身和特殊症状。88 例有完整的随访记录。最常开的药物为 、 、 和 ，而反应良好率最高的药物为 、 和 。接受顺势疗法治疗后完全康复的时间为 3.5 至 14.4 天，具体取决于所使用的药物。200c 浓度与更快的完全康复速度和更少的需要更换药物有关。
我们已经确定了西班牙轻度和中度 COVID-19 的顺势疗法治愈特征，并确定了一组可能被认为是有效传染病的药物。
